A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants

Clinical trial NCT04459585 · COMPLETED

Trial details

NCT number: NCT04459585
Sponsor: Daiichi Sankyo Co., Ltd.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Drug-drug Interaction Pharmacokinetics Quizartinib

Start date: 2020-08-28
Primary completion: 2020-10-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.